Comparative Pharmacokinetics and Glucodynamics of Two Human Insulin Mixtures 70/30 and 50/50 insulin mixtures

OBJECTIVE To compare and contrast the pharmacokinetics and glucodynamics of two insulin mixtures, one of 50% NPH human insulin and 50% Regular human insulin (50/50) and one of 70% NPH human insulin and 30% Regular human insulin (70/30), in healthy male volunteers after subcutaneous administrations of 0.3 U/kg. RESEARCH DESIGN AND METHODS We administered single doses of 50/50 and 70/30 insulins to 18 volunteers in a randomized crossover fashion. All subjects received 0.3 U/kg of each mixture separated by at least 7 days. Each dose was given after an overnight fast and during a glucose clamp to maintain a euglycemic state. We measured serum insulin and Cpeptide concentrations through frequent blood sampling after each treatment. Pharmacokinetic measurements were calculated from insulin data corrected for C-peptide, including maximum insulin concentration (Cmax), time to maximum insulin concentration (tmax), terminal rate constant (β), area under the curve from 0 to ∞, (AUC x0), and mean residence time (MRT). Pharmacodynamic measurements were summarized from C-peptide concentrations (minimum C-peptide concentration [Cmin], time to minimum C-peptide concentration [tmin], area between the C-peptide baseline and the C-peptide suppression curve [AOCc], absolute maximal difference from baseline [Sdiff] and glucose clamp measurements. The glucose clamp measurements included maximum infusion rates (Rmax) and time to Rmax (TRmax) from glucose infusion rate (GIR) documentation, as well as cumulative glucose infused during the first 4 h (40Gtot) and total glucose infused (Gtot) during the study. RESULTS For the pharmacokinetic assessment, statistically greater values of insulin Cmax and β were found for the 50/50 mixture, whereas the 70/30 mixture had a greater MRT. Statistical differences were also detected in glucodynamics, with greater values of Rmax and (40Gtot) found with the 50/50 mixture. Notably, differences were not detected for insulin AUCx0 and Gtot values. CONCLUSIONS Higher insulin concentrations and a greater initial response were present with the 50/50 mixture, but the two mixtures had equivalent bioavailability and cumulative effects. These results support use of the 50/50 mixture in situations where greater initial glucose control is required.

[1]  D. Howey,et al.  Establishment of Time-Action Profiles for Regular and NPH Insulin Using Pharmacodynamic Modeling , 1994, Diabetes Care.

[2]  R. Torella,et al.  Decreased insulin clearance as a feature of essential hypertension. , 1992, The Journal of clinical endocrinology and metabolism.

[3]  D. Cucinotta,et al.  Premixed insulin at ratio 3/7 and regular + isophane insulins at mixing ratios from 2/8 to 4/6 achieve the same metabolic control. , 1991, Diabete & metabolisme.

[4]  J. K. Radder,et al.  In Vivo Relationship Between Insulin Clearance and Action in Healthy Subjects and IDDM Patients , 1990, Diabetes.

[5]  G. Cutter,et al.  Efficacy of a premixed semisynthetic human insulin regimen. , 1989, Clinical Therapeutics.

[6]  J. Robert,et al.  The Contribution of Intermediate‐acting Insulin Preparations to Daytime Insulin Treatment , 1989, Diabetic medicine : a journal of the British Diabetic Association.

[7]  L Heinemann,et al.  The Action Profiles of Human NPH Insulin Preparations , 1989, Diabetic medicine : a journal of the British Diabetic Association.

[8]  R. Prager,et al.  Mixtures of human intermediate and human regular insulin in type 1 diabetic patients. Evaluation of free insulin levels and insulin action on glucose metabolism after combined and separate subcutaneous administration. , 1988, Diabetes research and clinical practice.

[9]  P. Olsson,et al.  Miscibility of Human Semisynthetic Regular and Lente Insulin and Human Biosynthetic Regular and NPH Insulin , 1987, Diabetes Care.

[10]  R. Heine,et al.  Absorption kinetics and action profiles of intermediate acting human insulins. , 1987, Diabetes research.

[11]  J. Corcoran,et al.  How Inaccurate is Insulin Mixing? Patient Variability and Syringe Dead Space Effect , 1985, Diabetic medicine : a journal of the British Diabetic Association.

[12]  J. Roland Need Stable Diabetics Mix their Insulins? , 1984, Diabetic Medicine.

[13]  G. Nell,et al.  Pharmacodynamics of Human Insulin (recombinant DNA)—Regular, NPH, and Mixtures—Obtained by the Gerritzen Method in Healthy Volunteers , 1982, Diabetes Care.

[14]  V. Jörgens,et al.  Absorption Kinetics and Biologic Effects of Subcutaneously Injected Insulin Preparations , 1982, Diabetes Care.

[15]  A. Katz,et al.  Quantitation of Human Pancreatic Beta-cell Function by Immunoassay of C-Peptide in Urine , 1977, Diabetes.